News | July 15, 2021
Sequent Scientific announces EUGMP approval for tablets
The company has already embarked upon significant expansion in Turkey
The company has already embarked upon significant expansion in Turkey
The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
The company recorded revenue of Rs 528crore as compared to Rs 444 crore, registering a growth of 19% over the corresponding quarter ended 31st March 2020
These five oxygen plants with a total capacity of 3,840 cubic meters of oxygen per day have been donated to Madhya Pradesh, Maharashtra, and Gujarat
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
Adjusted PAT declined 18.8% YoY
The GMP certificate is valid for three years until April 2024.
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India
Subscribe To Our Newsletter & Stay Updated
